Allianz Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11,948
| Closed | -$808K | – | 1572 |
|
|
2022
Q2 | $808K | Buy |
11,948
+1,016
| +9% | +$68.7K | ﹤0.01% | 1549 |
|
|
2022
Q1 | $1.21M | Sell |
10,932
-1,541
| -12% | -$170K | ﹤0.01% | 1501 |
|
|
2021
Q4 | $1.21M | Buy |
12,473
+3,610
| +41% | +$351K | ﹤0.01% | 1537 |
|
|
2021
Q3 | $774K | Buy |
8,863
+1,001
| +13% | +$87.4K | ﹤0.01% | 1644 |
|
|
2021
Q2 | $1.22M | Sell |
7,862
-3,857
| -33% | -$597K | ﹤0.01% | 1430 |
|
|
2021
Q1 | $1.85M | Sell |
11,719
-8,755
| -43% | -$1.38M | ﹤0.01% | 1294 |
|
|
2020
Q4 | $4.75M | Buy |
20,474
+7,486
| +58% | +$1.74M | ﹤0.01% | 1042 |
|
|
2020
Q3 | $2.84M | Sell |
12,988
-315
| -2% | -$69K | ﹤0.01% | 1132 |
|
|
2020
Q2 | $3.78M | Buy |
13,303
+6,945
| +109% | +$1.97M | ﹤0.01% | 1085 |
|
|
2020
Q1 | $1.83M | Buy |
6,358
+961
| +18% | +$277K | ﹤0.01% | 1272 |
|
|
2019
Q4 | $1.55M | Buy |
+5,397
| New | +$1.55M | ﹤0.01% | 1556 |
|
|
2019
Q1 | – | Sell |
-7,360
| Closed | -$1.03M | – | 2262 |
|
|
2018
Q4 | $1.03M | Buy |
7,360
+120
| +2% | +$16.9K | ﹤0.01% | 1666 |
|
|
2018
Q3 | $1.85M | Buy |
7,240
+652
| +10% | +$167K | ﹤0.01% | 1589 |
|
|
2018
Q2 | $1.68M | Buy |
+6,588
| New | +$1.68M | ﹤0.01% | 1573 |
|
|
2015
Q3 | – | Sell |
-6,576
| Closed | -$2.68M | – | 1892 |
|
|
2015
Q2 | $2.68M | Sell |
6,576
-3,936
| -37% | -$1.61M | ﹤0.01% | 1278 |
|
|
2015
Q1 | $4.83M | Buy |
+10,512
| New | +$4.83M | 0.01% | 1016 |
|